The €262.5 million all-cash acquisition was announced April 30, 2021
Ashland has completed its acquisition of Schülke & Mayr GmbH’s personal care business, the company announced 30th April. The news follows the announcement in January 2021 by Schülke & Mayr GmbH to focus on its core business of infection prevention and hygiene solutions and exit personal care.
Schülke & Mayr GmbH is a long-established business that develops, produces and distributes antiseptics for wound care, disinfectants and medical and cosmetic skin care products and preservatives. The company offers its customers innovative products, solutions and services in the professional healthcare business, over the counter (OTC) and hygiene solutions for the pharma sector.
The completion of the purchase is aimed at strengthening Ashland’s consumer business portfolio and beef up its specialty additives business while also growing the company’s biotechnology and microbiology technical offerings.
Guillermo Novo, Chairman and Chief Executive Officer, Ashland was quoted as saying “I am excited to welcome the Schülke and Mayr personal care employees to Ashland. They will help broaden our specialty additives solutions and expand our biotechnology and microbiology technical capabilities, We will continue driving our strategy and focusing on bolt-on acquisitions that create new sustainable solutions in broader fields of application to deliver value to our customers.”
“Completing this acquisition supports our strategy to strengthen the profitable growth of our personal care and household business unit,” said Xiaolan Wang, senior vice president and general manager, personal care and household, Ashland. “It is my pleasure to welcome our new solvers to Ashland who will further help our customers’ brands differentiate and grow in a constantly changing market space.”